Azelaic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00548 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | demodicidosis of sebaceous gland | KG + DL |
| 2 | cutaneous candidiasis | KG + DL |
| 3 | lichen planus, familial | KG + DL |
| 4 | zinc, elevated plasma | KG + DL |
| 5 | isolated congenital adermatoglyphia | KG + DL |
| 6 | keratinization disease | KG + DL |
| 7 | seborrheic dermatitis | KG + DL |
| 8 | nail infection | KG + DL |
| 9 | tinea corporis | KG + DL |
| 10 | Beare-Stevenson cutis gyrata syndrome | KG + DL |
| 11 | familial chilblain lupus | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.